Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARS Pharmaceuticals, Inc. | Chief Operating Officer | Common Stock | 6.02K | $90.4K | $15.00 | Aug 20, 2024 | Direct |
ARS Pharmaceuticals, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 61.8K | Aug 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals, Inc. | Aug 20, 2024 | 3 | -$718K | 4 | Aug 21, 2024 | Chief Operating Officer |
SPRY | ARS Pharmaceuticals, Inc. | Aug 13, 2024 | 3 | -$371K | 4 | Aug 15, 2024 | Chief Operating Officer |
SPRY | ARS Pharmaceuticals, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Chief Operating Officer |
SPRY | ARS Pharmaceuticals, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Operating Officer |
SPRY | ARS Pharmaceuticals, Inc. | Dec 6, 2022 | 0 | $0 | 3 | Dec 9, 2022 | Chief Operating Officer |